Seo-Hee Ahn

Title: Innovations by Seo-Hee Ahn in Dendritic Cell Maturation

Introduction

Seo-Hee Ahn is a notable inventor based in Gwangju-si, South Korea. He has made significant contributions to the field of immunology, particularly in the maturation of dendritic cells. His work focuses on enhancing the immune response, which is crucial for effective immunotherapy.

Latest Patents

Seo-Hee Ahn holds a patent for a composition aimed at maturing dendritic cells. The patent, titled "Composition for maturing dendritic cells, and method for preparing antigen-specific dendritic cells using same," includes a combination of maturation-promoting factors such as Interleukin-1β (IL-1β), Interleukin-6 (IL-6), Tumor necrosis factor-α (TNF-α), Interferon-γ (IFN-γ), Prostaglandin E2 (PGE2), Picibanil (OK432), and/or Poly IC. This innovative composition not only improves the ability of dendritic cells to induce an immune response but also reduces the antigen non-specific immune response while enhancing the antigen-specific immune response.

Career Highlights

Seo-Hee Ahn is currently associated with Jw Creagene Inc., where he continues to advance his research in immunology. His work has the potential to maximize the effects of immunotherapy, making significant strides in the treatment of various diseases.

Collaborations

Seo-Hee Ahn collaborates with talented individuals in his field, including Yoon Young Lee and Hye-Won Kang. Their combined expertise contributes to the innovative research and development of new immunological therapies.

Conclusion

Seo-Hee Ahn's contributions to dendritic cell maturation represent a significant advancement in immunotherapy. His innovative approaches and collaborations are paving the way for future breakthroughs in the field.